Price
No data yet.
Social Signal Score
Revenue
$2.36B+1105.25%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Junling Liu
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 1,063
- Beta
- 0.65
- Country
- CN
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- 37.93
Financials
Revenue
$2.36B+1105.3%Net Income
$-37.04MEBITDA
$-18.94MFree Cash Flow
$-91.72MEPS (diluted)
$-4.20Shares Outstanding (diluted)
8.79M+144.3%Operating Expenses
$70.66MCash & Debt
$53.09MReturn of Capital
$0.00Revenue by Segment (annual)
$25.11BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $12.21B | $-16.84M | $-7.42 |
| 2024 | $14.40B | $-64.74M | $-7.52 |
| 2023 | $14.95B | $-392.69M | $-46.58 |
| 2022 | $13.52B | $-416.88M | $-50.04 |
| 2021 | $12.43B | $-669.81M | $-80.76 |
| 2020 | $8.20B | $-456.53M | $-55.40 |
| 2019 | $3.95B | $-499.61M | $-60.16 |
| 2018 | $1.79B | $-380.09M | $-76.44 |
| 2017 | $959.49M | $-248.58M | $-69.04 |
| 2016 | $873.84M | $-362.68M | $-116.10 |
Valuation
YIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (3)
- Newsprnewswire.com·7h ago·Neutral
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company SHANGHAI, Sept. 17, 2026 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated September 16, 2026 jointly submitted by Dr. Gang Yu, co-founder and co-chairman of the Company, Mr.
View source ↗ - Newsgurufocus.com·8h ago·Neutral
111, Inc. Announces Second Quarter 2026 Unaudited Financial Results 111, Inc. Announces Second Quarter 2026 Unaudited Financial ResultsPR NewswireSHANGHAI, Sept. 17, 2026Transition from An Asset-Heavy Business Model to An Asset-
View source ↗ - Newsprnewswire.com·9h ago·Neutral
…nt Expenses as a Percentage of Revenue Improved by 5 Basis Points Year-over-Year SHANGHAI, Sept. 17, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the second quarter ended June 30, 2026.
View source ↗
Earnings
Thu, Nov 26(in 2 months)
Estimates and results for YI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by YI officers and directors.
- Bought
- —
- Sold
- $141k
0 trades
12 trades
- Chen Yang Lukesold
- Sun Jian Davidsold
- Chen Yang Lukesold
- Sun Jian Davidsold
- Sun Jian Davidsold
- Sun Jian Davidsold
- Luo Jun Justinsold
- Sun Jian Davidsold
32 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in YI.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.